|

National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup

RECRUITINGSponsored by Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Actively Recruiting
SponsorGesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
Started2014-07
Est. completion2024-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02192619

Summary

The registry aims to document epidemiologic data, treatment and long-term outcome as well as quality of life of patients with APL. Additionally, a biobanking project for further translational studies is integrated. Prospective population-based non-interventional and non-randomized multicenter registry.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* newly-diagnosed APL (either de novo or therapy-related), within 12 months of diagnosis
* or relapsed APL, within 12 months of diagnosis of relapse

  1. confirmed by the presence of the translocation t(15; 17)
  2. and / or confirmed by the detection of the fusion transcript of PML/RARa

Exclusion Criteria:

* none

Conditions3

CancerNewly-diagnosed APL (de Novo or Therapy-related)Relapsed APL

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.